- mail us help@24marketresearch.com
- Int'l 1(332) 2424 294 (Int'l)
TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Necrotic Enteritis (NE) is a significant enteric disease that primarily affects poultry, causing severe damage to the intestinal epithelium. The disease leads to the formation of necrotic patches in the intestines, disrupting digestion and nutrient absorption. It primarily affects juvenile broilers, leading to increased mortality and reduced productivity in the poultry industry. The treatment market for necrotic enteritis focuses on providing solutions to control and prevent this disease, including medications, probiotics, and vaccines. These treatments are crucial for maintaining the health of poultry flocks, ensuring high yield and economic sustainability in the poultry industry.
The global necrotic enteritis treatment market was valued at USD 25,000 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.00% from 2024 to 2032, reaching approximately USD 42,954.65 million by 2032.
The market's growth is driven by the increasing demand for poultry products, growing awareness of poultry diseases, and advancements in treatment methods, including the use of probiotics, vaccines, and antibiotics. The market size is expanding as the poultry industry is increasingly focusing on improving flock health and production efficiency.
In recent years, the market has experienced steady growth, driven by rising concerns about animal health and the increasing prevalence of necrotic enteritis in poultry populations worldwide. Advances in veterinary medicine and an increased emphasis on sustainable and effective disease management are also contributing factors to this market's growth trajectory.
Drivers
Rising Poultry Production: The growing global demand for poultry meat and eggs is fueling the need for effective treatments to control diseases like necrotic enteritis. With poultry being a significant source of protein worldwide, managing diseases becomes critical to meet production targets.
Increasing Awareness: Increased awareness among poultry farmers about the prevention and treatment of necrotic enteritis is driving the demand for innovative solutions. Educational programs and veterinary consultations have helped highlight the importance of early detection and treatment.
Advancements in Treatment Options: The development of novel probiotics, vaccines, and antibiotic alternatives is improving the treatment landscape. These innovations provide poultry farmers with more efficient and sustainable ways to manage necrotic enteritis outbreaks.
Restraints
High Treatment Costs: The cost of treatments, including veterinary consultations, medications, and vaccines, can be a significant financial burden for smaller poultry farms, limiting market growth in regions with less economic stability.
Regulatory Barriers: Stringent regulations regarding the use of antibiotics and other treatment options in livestock farming could hamper market expansion, particularly in regions with strict food safety standards.
Opportunities
Untapped Markets in Emerging Economies: As poultry farming continues to grow in regions like Asia-Pacific and Latin America, there is an increasing opportunity to introduce advanced necrotic enteritis treatments in these emerging markets.
Research and Development: Ongoing research into developing more effective and environmentally sustainable treatments presents opportunities for pharmaceutical companies to capitalize on unmet needs in the market.
Challenges
Antibiotic Resistance: The overuse of antibiotics in poultry farming has led to growing concerns over antibiotic resistance, necessitating the development of alternative treatments to ensure the long-term effectiveness of therapies.
Disease Management Complexity: Necrotic enteritis can be difficult to diagnose in its early stages, making timely intervention challenging for poultry farmers. This lack of early detection methods can hinder effective disease management.
North America
In 2024, North America accounted for a substantial share of the necrotic enteritis treatment market, estimated at USD 7,319.45 million. This region is expected to maintain steady growth at a CAGR of 6.00% from 2025 through 2032. The high demand for poultry products and the presence of leading pharmaceutical companies contributing to the development of new treatment options are key factors driving this market.
Europe
Europe is a significant player in the necrotic enteritis treatment market, driven by robust poultry farming practices and advanced veterinary healthcare systems. Countries like the UK, France, and Germany have well-established poultry industries, contributing to the demand for effective disease management solutions.
Asia-Pacific
The Asia-Pacific region is poised to witness the highest growth in the coming years, driven by the expanding poultry industry in countries such as China, India, and Southeast Asia. The increasing focus on animal health and the rising demand for high-quality poultry products in these nations are key growth factors.
South America and MEA
Emerging markets in South America and the Middle East and Africa (MEA) region also offer growth potential for necrotic enteritis treatment. Rising poultry production and improvements in veterinary care will likely drive market growth in these regions.
Competitor Analysis (in brief)
Key players in the necrotic enteritis treatment market include:
Prometic Life Sciences Inc.
BioGaia Probiotics
Fresenius Kabi AG
Actavis Plc.
Bayer International
Alcon Laboratories Inc.
Bausch & Lomb Incorporated
GlaxoSmithKline plc.
Pfizer
Transo-Pharm
Rochem International
HELM Portugal
These companies play a crucial role in the development and distribution of treatment solutions for necrotic enteritis. They focus on innovative product offerings, strategic collaborations, and expanding their presence in emerging markets to enhance their competitive positioning.
This report provides a deep insight into the global necrotic enteritis treatment market, covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and assessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Necrotic Enteritis Treatment Market. This report introduces in detail the market share, market performance, product situation, operation situation, etc., of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the necrotic enteritis treatment market in any manner.
Hospital
Clinic
Home
Oral
Parenteral
Prometic Life Sciences Inc.
BioGaia Probiotics
Fresenius Kabi AG
Actavis Plc.
Bayer International
Alcon Laboratories Inc.
Bausch & Lomb Incorporated
GlaxoSmithKline plc.
Pfizer
Transo-Pharm
Rochem International
HELM Portugal
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Colombia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
What is the current market size of Necrotic Enteritis Treatment?
Which are the key companies operating in the Necrotic Enteritis Treatment market?
What are the key growth drivers in the Necrotic Enteritis Treatment market?
Which regions dominate the Necrotic Enteritis Treatment market?
What are the emerging trends in the Necrotic Enteritis Treatment market?